Sisebenzisa isayensi ephucukileyo ukwenza amayeza amatsha azakuphucula ubomi babo banomhlaza, iintlungu ezinganyangekiyo kunye ne-COVID-19.
Cancer yohluka ngokwemfuza, iguquguquka kakhulu, iyaguquka rhoqo kwaye ayibonakali kumajoni omzimba. Indlela yethu yonyango lomhlaza isekelwe kwinkolelo yokuba izigulana ziya kufuna indlela ye-multimodal, i-multipronged-ijolise kwiseti enye okanye eyahlukeneyo yeethagethi zeselula kunye nokuhlasela abo bakwimida emininzi - ngaxeshanye okanye ngokulandelelana, rhoqo kwaye ngokungapheliyo.
Indlela yethu yokulwa nomhlaza yenziwa yenzeke ngepotfoliyo ekhethekileyo ye-immuno-oncology ("IO"), equlathe uluhlu olubanzi lwezinto ezintsha kunye ne-synergistic asethi, njengethala leencwadi elibanzi eligcwele amajoni omzimba ("G-MAB™") elinako zisetyenziswe ngokwazo okanye zibandakanywe kwiindlela zokujolisa umhlaza kubandakanya:
Ezi mpahla zexabiso zincediswa sisixhobo esisungulayo sokujolisa kwi-lymphatic (Sofusa®) eyenzelwe ukuhambisa amajoni omzimba kwisistim se-lymphatic, apho iiseli zamajoni omzimba ziqeqeshelwa ukulwa nomhlaza.
Siye savelisa izilwa-buhlungu zabantu ngokuchasene neethagethi ezininzi ezibalulekileyo kunyango lomhlaza, kubandakanywa i-PD-1, i-PD-L1, i-CD38, i-CD123, i-CD47, i-c-MET, i-VEGFR2, kunye nezinye iithagethi ezininzi, ezikumanqanaba ahlukeneyo ophuhliso. Iinkqubo zethu ze-CAR-T ziquka inqanaba lonyango lwe-CD38 CAR T. Unyango oludibanisa iindlela zonyango lukwinqanaba lokuvavanywa kwangaphambili kwi-myeloma emininzi, umhlaza wemiphunga, kunye neminye imihlaza yabantu abadala kunye nabantwana.
- I-CAR T (i-Chimeric Antigen Receptor-T Cells) unyango oluguqula iiseli ze-T zesigulana ukuba zibulale ithumba labo.
- I-DAR T (i-Dimeric Antigen Receptor-T Cells) unyango oluguqula iiseli ze-T zomnikeli osempilweni ukuba zisebenze nakwesiphi na ithumba lesigulana, nto leyo evumela unyango “lokuphuma kwishelufu” lwethumba lesigulana.
- I-Antibody-Drug Conjugates ("ADCs"), kunye
- Iinkqubo ze-Oncolytic Virus (Seprehvir™, Seprehvec™)
“Ipotfoliyo yethu eyodwa yee-asethi zeqonga le-IO ayinakuthelekiswa nanto kushishino. Ibandakanya i-immune checkpoint inhibitors, i-bispecific antibodies, i-antibody-drug conjugates (ADCs) kunye ne-chimeric antigen receptor (CAR) kunye ne-dimeric antigen receptor (DAR) esekelwe kunyango lweselula, kwaye kutsha nje songeze iintsholongwane ze-oncolytic (Seprehvir™, Seprehvec). ™). I-asethi nganye ibonisa isithembiso esikhulu; xa sidityanisiwe siziva benamandla okuphelisa eyona mingeni inzima yomhlaza”
– UGqr Henry Ji, CEO
Ukuzibophezela kwethu ekuphuculeni ubomi bezigulane ezineentlungu ezicatshangelwayo ngoku zibonakaliswa ngumgudu wethu ongapheliyo wokuphuhlisa i-agonist yokuqala (i-TRPV1 agonist) i-molecule encinci ye-opioid, i-Resiniferatoxin ("RTX").
I-Resiniferatoxin inamandla okutshintsha ngokunzulu indlela yokulawula intlungu kwiimpawu ezahlukeneyo, ngenxa yempembelelo enamandla kunye nexesha elide kunye nolawulo olulodwa kodwa nangenxa yeenzuzo zeprofayili yayo engeyiyo i-opioid.
I-RTX igqibezela ulingo oluphambili kwimiqondiso yabantu efana ne-osteoarthritis kunye nokuphela kweentlungu zomhlaza wobomi, kunye nezifundo zobhaliso ezibalulekileyo ezicwangciselwe ukuqalisa isiqingatha sesibini sika-2020.
I-RTX ikwakuvavanyo olubalulekileyo lokusetyenziswa kwizinja ezingamaqabane ekunzima ukulawula iintlungu zengqiniba samathambo. Njengoko izilwanyana ezifuywayo ziyinxalenye yentsapho, indlela yethu yokuphuhlisa izisombululo ezintsha zokulawula iintlungu zenzelwe ukubandakanya ezinye iintlobo esizithandayo!